Kevin Roedl1, Gerold Söffker2, Dominik Fischer3, Jakob Müller2,4, Dirk Westermann5, Malte Issleib3, Stefan Kluge2, Dominik Jarczak2. 1. Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. k.roedl@uke.de. 2. Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. 3. Department of Anaesthesiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. 4. Department of Anaesthesia, Tabea Hospital, Hamburg, Germany. 5. Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
Abstract
BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), an emerging virus, has caused a global pandemic. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to high hospitalization rates worldwide. Little is known about the occurrence of in-hospital cardiac arrest (IHCA) and high mortality rates have been proposed. The aim of this study was to investigate the incidence, characteristics and outcome of IHCA during the pandemic in comparison to an earlier period. METHODS: This was a retrospective analysis of data prospectively recorded during 3-month-periods 2019 and 2020 at the University Medical Centre Hamburg-Eppendorf (Germany). All consecutive adult patients with IHCA were included. Clinical parameters, neurological outcomes and organ failure/support were assessed. RESULTS: During the study period hospital admissions declined from 18,262 (2019) to 13,994 (2020) (- 23%). The IHCA incidence increased from 4.6 (2019: 84 IHCA cases) to 6.6 (2020: 93 IHCA cases)/1000 hospital admissions. Median stay before IHCA was 4 (1-9) days. Demographic characteristics were comparable in both periods. IHCA location shifted towards the ICU (56% vs 37%, p < 0.01); shockable rhythm (VT/VF) (18% vs 29%, p = 0.05) and defibrillation were more frequent in the pandemic period (20% vs 35%, p < 0.05). Resuscitation times, rates of ROSC and post-CA characteristics were comparable in both periods. The severity of illness (SAPS II/SOFA), frequency of mechanical ventilation and frequency of vasopressor therapy after IHCA were higher during the 2020 period. Overall, 43 patients (12 with & 31 without COVID-19), presented with respiratory failure at the time of IHCA. The Horowitz index and resuscitation time were significantly lower in patients with COVID-19 (each p < 0.01). Favourable outcomes were observed in 42 and 10% of patients with and without COVID-19-related respiratory failure, respectively. CONCLUSION: Hospital admissions declined during the pandemic, but a higher incidence of IHCA was observed. IHCA in patients with COVID-19 was a common finding. Compared to patients with non-COVID-19-related respiratory failure, the outcome was improved.
BACKGROUND:Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), an emerging virus, has caused a global pandemic. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to high hospitalization rates worldwide. Little is known about the occurrence of in-hospital cardiac arrest (IHCA) and high mortality rates have been proposed. The aim of this study was to investigate the incidence, characteristics and outcome of IHCA during the pandemic in comparison to an earlier period. METHODS: This was a retrospective analysis of data prospectively recorded during 3-month-periods 2019 and 2020 at the University Medical Centre Hamburg-Eppendorf (Germany). All consecutive adult patients with IHCA were included. Clinical parameters, neurological outcomes and organ failure/support were assessed. RESULTS: During the study period hospital admissions declined from 18,262 (2019) to 13,994 (2020) (- 23%). The IHCA incidence increased from 4.6 (2019: 84 IHCA cases) to 6.6 (2020: 93 IHCA cases)/1000 hospital admissions. Median stay before IHCA was 4 (1-9) days. Demographic characteristics were comparable in both periods. IHCA location shifted towards the ICU (56% vs 37%, p < 0.01); shockable rhythm (VT/VF) (18% vs 29%, p = 0.05) and defibrillation were more frequent in the pandemic period (20% vs 35%, p < 0.05). Resuscitation times, rates of ROSC and post-CA characteristics were comparable in both periods. The severity of illness (SAPS II/SOFA), frequency of mechanical ventilation and frequency of vasopressor therapy after IHCA were higher during the 2020 period. Overall, 43 patients (12 with & 31 without COVID-19), presented with respiratory failure at the time of IHCA. The Horowitz index and resuscitation time were significantly lower in patients with COVID-19 (each p < 0.01). Favourable outcomes were observed in 42 and 10% of patients with and without COVID-19-related respiratory failure, respectively. CONCLUSION: Hospital admissions declined during the pandemic, but a higher incidence of IHCA was observed. IHCA in patients with COVID-19 was a common finding. Compared to patients with non-COVID-19-related respiratory failure, the outcome was improved.
Entities:
Keywords:
COVID-19; Cardiac arrest; Cardiopulmonary resuscitation; Corona virus disease; In-hospital cardiac arrest; Intensive care unit; Multiple organ failure; SARS-COV-2
Authors: Jerry P Nolan; Robert A Berg; Lars W Andersen; Farhan Bhanji; Paul S Chan; Michael W Donnino; Swee Han Lim; Matthew Huei-Ming Ma; Vinay M Nadkarni; Monique A Starks; Gavin D Perkins; Peter T Morley; Jasmeet Soar Journal: Resuscitation Date: 2019-09-16 Impact factor: 5.262
Authors: André Ly; Claire Alessandri; Elena Skripkina; Arnaud Meffert; Simon Clariot; Quentin de Roux; Olivier Langeron; Nicolas Mongardon Journal: Resuscitation Date: 2020-05-20 Impact factor: 5.262
Authors: Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes Journal: Intensive Care Med Date: 2020-03-28 Impact factor: 17.440
Authors: Marco A F Pimentel; Oliver C Redfern; Robert Hatch; J Duncan Young; Lionel Tarassenko; Peter J Watkinson Journal: Resuscitation Date: 2020-09-10 Impact factor: 5.262
Authors: William J Brady; Summer Chavez; Michael Gottlieb; Stephen Y Liang; Brandon Carius; Alex Koyfman; Brit Long Journal: Am J Emerg Med Date: 2022-04-27 Impact factor: 4.093
Authors: Karol Bielski; Katarzyna Makowska; Adam Makowski; Tomasz Kopiec; Aleksandra Gasecka; Mariola Malecka; Michal Pruc; Zubaid Rafique; Frank W Peacock; Andrea Denegri; Lukasz Szarpak Journal: Cardiol J Date: 2021 Impact factor: 2.737
Authors: Julia M Edwards; Jerry P Nolan; Jasmeet Soar; Gary B Smith; Emily Reynolds; Jane Carnall; Kathryn M Rowan; David A Harrison; James C Doidge Journal: Resuscitation Date: 2022-02-10 Impact factor: 6.251
Authors: Kayla M Secrest; Theresa M Anderson; Brad Trumpower; Molly Harrod; Sarah L Krein; Timothy C Guetterman; Paul S Chan; Brahmajee K Nallamothu Journal: Resusc Plus Date: 2022-10-11
Authors: Kevin Roedl; Gerold Söffker; Dominic Wichmann; Olaf Boenisch; Geraldine de Heer; Christoph Burdelski; Daniel Frings; Barbara Sensen; Axel Nierhaus; Dirk Westermann; Stefan Kluge; Dominik Jarczak Journal: J Clin Med Date: 2021-05-19 Impact factor: 4.241